Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001048577 | SCV001212590 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2024-12-23 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268417 | SCV002550429 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004031517 | SCV002731766 | likely benign | Nephrolithiasis/nephrocalcinosis | 2019-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |